
IP unlocks startup valuation – Part I
Chris Baxter shares how to use IP to unlock startup valuation at the pre-traction stage in the first Part of the series Why Investors Always Ask About IP.
With our experienced and communicative team of 8 patent attorneys, all of whom are patent industry experts, you can benefit from working with a patent attorney who specialises in your technology area:
If you work in the fast-evolving fintech or SaaS space, patent protection is necessary to protect the steps you have taken ahead of other players because these gaps can be closed quickly. If you work in developing new chemical processes, compounds and pharmaceutical formulations, there is often an extended development lifecycle before a commercial return can be seen. Often there is a scientific community push for publishing advances to establish a pseudo claim of first to invent – this needs to be resisted until a patent application has been filed by your patent attorney; otherwise, publication may adversely affect the ability to obtain adequate and deserved commercial compensation for the substantial investment you have made.
Chris Baxter shares how to use IP to unlock startup valuation at the pre-traction stage in the first Part of the series Why Investors Always Ask About IP.
Mike Biagio discusses the case of Vald Performance vs Kangatech, which demonstrates the outcome of a license that is not done properly and why you need an IP solictor’s advice in drafting exclusive licenses.
A CRISPR patent was revoked due to unsuccessful transfer of priority rights to Europe through PCT.